BRDX — Warrant Overhang Watching for the Next Big Bang

BDRX: The Bullish Retest

ACCUMULATION ZONE: $3.25 - $3.40

The market is currently digesting the 1-for-5 reverse ADR split (effective April 6). While the 14% drop from yesterday's close looks aggressive, the data reveals a textbook "Gap-Fill & Go" setup. Today’s light-volume drift is likely a shakeout of weak hands before the next leg of the Syngene-backed rally.

Last Trade$3.32

Warrant Floor$3.28

Market Cap$10.9M

Rel. Vol~200K

1. Post-Split Price Plan (5x Adjusted)

Every level from our April 2nd breakout thesis remains valid when scaled by the 5x split multiplier. We are currently sitting at the very edge of the "Momentum Entry" zone.

Phase	Pre-Split Target	Post-Split Equivalent
Momentum Entry	$0.87+	$4.35+
Core Target 1	$1.05 - $1.10	$5.25 - $5.50
Retest April 2 Highs	$1.35	$6.75
Invalidation / Stop	$0.68	$3.40 (Watch $3.28)

2. Understanding the "Warrant Floor"

Why $3.28 is the Critical Number

Biodexa recently registered Series L Warrants with an exercise price of $3.28. During the April 2nd surge, warrant holders used the liquidity to exercise and sell, creating a "ceiling" near $6.00. However, as the price retreats, that $3.28 level now acts as a hard mechanical floor. If the stock holds here, it suggests the "toxic" supply has been absorbed by new accumulation.

3. Why This Isn't a "Dead Cat Bounce"

Unlike standard penny stock pumps, BDRX is backed by significant fundamental shifts that separate this retracement from a collapse:

• Syngene Partnership: GMP manufacturing for MTX240 is secured, removing the primary operational risk for clinical trials.
• Volume Divergence: Today's 200K volume is less than 0.5% of the 120M traded on April 2. Selling is thin; the major players are still holding.
• Earnings Window: Q1 earnings (Est. April 10) provide a major catalyst for management to update the cash runway (currently into Q3 2026).

4. Trader Sentiment Analysis

Retail sentiment on X has turned cautious after a "bearish cross" flagged on scanners. This negative buzz is often a contrarian signal for a swing entry. While day traders shorted the $5.85 fade, the swing crowd is now eyeing the $3.28–$3.30 zone for the "second leg" of the move.

VIEW LIVE BDRX CHART ON TRADINGVIEW

DISCLAIMER: This analysis is for educational purposes and reflects a bullish swing perspective on BDRX. Micro-cap biotechs carry extreme risk, and reverse splits often lead to high volatility. This is not financial advice; always manage your position size and do your own due diligence.